Mullerian Inhibiting Substance
Taylor, Lesli A.
Massachusetts General Hospital, Boston, MA, United States
See 4 grants from Lesli Taylor
See 24423 grants from Massachusetts General Hospital
Recent in Grantomics:
University of Virginia
vs. funders. Who wins?
How should you pick the next fundable research topic?
Recently viewed grants:
Driving forces of membrane protein assembly in membranes
Oncogenic mechanisms and molecular targets in lymphoma
Humanization of VLR antibodies for therapeutic applications
Epigenome maps of regulatory activity in Xenopus tropicalis embryos
Role of p27 in chronic myeloid leukemia and its potential as a therapeutic target
Recently added grants:
Defining the pathway of alphavirus capsid assembly into viral particles
Roles of endothelial tensins
The Nature and Function of Genomic Imprinting in Monoaminergic Neurons
Assessment of a Community Support Worker Intervention for PLWH in Rural Ethiopia
3/3-Schizophrenia Genetics and Brain Somatic Mosaicism
National Institute of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Postdoctoral Individual National Research Service Award (F32)
Clinical Sciences Subcommittee 1 (CLN)
Massachusetts General Hospital
MacLaughlin, D T; Levin, R K; Catlin, E A et al.
Identification of mullerian inhibiting substance specific binding in human cell lines.
Horm Metab Res 24:570-5
Be the first to comment on Lesli Taylor's grant
Share this grant: